NSE · JAGSNPHARM
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,392
of 5,047 stocks
▼ 91W▼ 31M
Peak #1,323 · 27 Sep 2026
Jagsonpal Pharmaceuticals Limited is a smallcap company in the Healthcare space and remains firmly promoter-controlled, with promoters holding 69%, is growing revenue modestly, and commands a premium earnings multiple.
Market Cap
1,415.73 Cr
P/E Ratio
33.49
P/B Ratio
5.20
ROE
15.60%
ROCE
21.02%
Dividend Yield
1.87%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 96.37 Cr | 82.23 Cr | 64.20 Cr | 72.94 Cr |
| Net Profit | 12.29 Cr | 13.19 Cr | 8.76 Cr | 10.95 Cr |
| EPS | 1.86 | 2.00 | 1.25 | 1.67 |
| Operating Profit | 16.94 Cr | 17.93 Cr | 12.01 Cr | 16.86 Cr |
Shareholding pattern
Promoter
69.05%
Public
30.95%
PUBLIC BREAKDOWN
FII
2.30%
DII
0.62%
MF (within DII)
0.00%
Individuals
19.98%
Mutual fund holdings
₹0.02
Cr total
2
Schemes
2
Fund Houses
₹0.02 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.01 Cr (67.8%)
Bandhan Mutual Fund₹0.00 Cr (32.2%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 04 Sep 2026 | Dividend | Dividend - Rs 4 Per Share |
| 04 May 2026 | Buyback | Buy Back |
| 12 Sep 2025 | Dividend | Dividend - Rs 2.50 Per Share |
| 08 Jan 2025 | Split | Face Value Split (Sub-Division) - From Rs 5/- Per Share To Rs 2/- Per Share |
| 06 Sep 2024 | Dividend | Dividend - Rs 5 Per Share |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.